These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 30348169)

  • 1. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway.
    Sun T; Zhang K; Pangeni RP; Wu J; Li W; Du Y; Guo Y; Chaurasiya S; Arvanitis L; Raz DJ
    Mol Cancer Res; 2021 Mar; 19(3):429-440. PubMed ID: 33298547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G9A promotes tumor cell growth and invasion by silencing CASP1 in non-small-cell lung cancer cells.
    Huang T; Zhang P; Li W; Zhao T; Zhang Z; Chen S; Yang Y; Feng Y; Li F; Shirley Liu X; Zhang L; Jiang G; Zhang F
    Cell Death Dis; 2017 Apr; 8(4):e2726. PubMed ID: 28383547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and invasion by inhibiting G9a in non-small-cell lung cancer A549 cells.
    Zhang L; Liang B; Xu H; Gong Y; Hu W; Jin Z; Wu X; Chen X; Li M; Shi L; Shi Y; Wang Y; Yang L
    J Ethnopharmacol; 2022 Jun; 291():115095. PubMed ID: 35176466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer.
    Pangeni RP; Yang L; Zhang K; Wang J; Li W; Guo C; Yun X; Sun T; Wang J; Raz DJ
    Clin Epigenetics; 2020 Jun; 12(1):88. PubMed ID: 32552834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway.
    Wang L; Dong X; Ren Y; Luo J; Liu P; Su D; Yang X
    Cell Death Dis; 2018 Jan; 9(2):129. PubMed ID: 29374157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM.
    Chen MW; Hua KT; Kao HJ; Chi CC; Wei LH; Johansson G; Shiah SG; Chen PS; Jeng YM; Cheng TY; Lai TC; Chang JS; Jan YH; Chien MH; Yang CJ; Huang MS; Hsiao M; Kuo ML
    Cancer Res; 2010 Oct; 70(20):7830-40. PubMed ID: 20940408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RETRACTED: KDM4A promotes the growth of non-small cell lung cancer by mediating the expression of Myc via DLX5 through the Wnt/β-catenin signaling pathway.
    Sun S; Yang F; Zhu Y; Zhang S
    Life Sci; 2020 Dec; 262():118508. PubMed ID: 33002480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
    Zhang Z; Yang Y; Zhang X
    Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
    Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Regulation of the PTEN-AKT-RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma.
    Bhat AV; Palanichamy Kala M; Rao VK; Pignata L; Lim HJ; Suriyamurthy S; Chang KT; Lee VK; Guccione E; Taneja R
    Cancer Res; 2019 May; 79(9):2232-2243. PubMed ID: 30833420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
    Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
    J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3.
    Leng X; Wang J; An N; Wang X; Sun Y; Chen Z
    Oncogene; 2020 Oct; 39(41):6468-6479. PubMed ID: 32879445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
    Lin X; Huang Y; Zou Y; Chen X; Ma X
    Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis.
    Casciello F; Al-Ejeh F; Kelly G; Brennan DJ; Ngiow SF; Young A; Stoll T; Windloch K; Hill MM; Smyth MJ; Gannon F; Lee JS
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7077-7082. PubMed ID: 28630300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression.
    Zhao L; Li S; Gan L; Li C; Qiu Z; Feng Y; Li J; Li L; Li C; Peng W; Xu C; Wang Z; Hui T; Ren G; Tao Q; Xiang T
    J Cell Mol Med; 2016 May; 20(5):842-54. PubMed ID: 26843424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.
    Toyokawa G; Cho HS; Masuda K; Yamane Y; Yoshimatsu M; Hayami S; Takawa M; Iwai Y; Daigo Y; Tsuchiya E; Tsunoda T; Field HI; Kelly JD; Neal DE; Maehara Y; Ponder BA; Nakamura Y; Hamamoto R
    Neoplasia; 2011 Oct; 13(10):887-98. PubMed ID: 22028615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EHMT2 epigenetically suppresses Wnt signaling and is a potential target in embryonal rhabdomyosarcoma.
    Pal A; Leung JY; Ang GCK; Rao VK; Pignata L; Lim HJ; Hebrard M; Chang KT; Lee VK; Guccione E; Taneja R
    Elife; 2020 Nov; 9():. PubMed ID: 33252038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.
    Yokoyama M; Chiba T; Zen Y; Oshima M; Kusakabe Y; Noguchi Y; Yuki K; Koide S; Tara S; Saraya A; Aoyama K; Mimura N; Miyagi S; Inoue M; Wakamatsu T; Saito T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Yokosuka O; Iwama A
    Oncotarget; 2017 Mar; 8(13):21315-21326. PubMed ID: 28423509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-625 inhibits the progression of non‑small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway.
    Tan X; Jiang L; Wu X; Feng W; Lin Q
    Int J Mol Med; 2019 Jul; 44(1):346-356. PubMed ID: 31115501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.